All-trans retinoic acid (ATRA) has recently been shown to treated with IFN␣ could be significantly longer than that of synergise with the inhibitory effect of interferon alpha (IFN␣) patients receiving conventional chemotherapy. solid CFC assays. To analyze whether this association had a
Introduction
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder characterized by the acquisition of the PhiladelMaterials and methods phia chromosome (Ph) in leukemic stem cells and their progeny. 1, 2 The abnormal Ph chromosome is the result of a reciprocal translocation between chromosome 9 and 22. The Patients major consequence of this translocation is the fusion of the ABL gene to the BCR gene on chromosome 22. 3 The BCR/ABL gene is transcribed into a chimeric 8.6 kb mRNA which encoBlood cells from 16 patients with newly diagnosed Ph-positive des a 210 kDa hybrid protein 4 and is probably responsible for CML were obtained from cytapheresis performed at diagnosis the chronic phase of the disease. 5 The cells belonging to the before any treatment. 21 All patients were in chronic phase, malignant clone can be detected by either chromosome with 100% Ph-positive metaphases in cytogenetical analysis. analysis or techniques designed to monitor the expression of Informed consent was given in every case. the BCR/ABL chimeric mRNA or P210 hybrid protein. 6, 7 Allogeneic bone marrow transplantation is the only curative treatment for CML patients but it is applicable only for young patients who have an HLA-identical sibling or more rarely an Cell isolation procedures unrelated donor. 8, 9 Using partially purified leukocyte interferon or more recently recombinant alpha interferon (IFN␣), MNC were obtained by Ficoll-Hypaque density gradient cenit has been shown that complete hematological remissions trifugation (d = 1.077; Seromed, Biochrom KG, Berlin, could be achieved in most patients with newly diagnosed Germany). CD34 + cells were obtained using an immunomag-CML and that a substantial proportion of patients could netic separation protocol (Isolex 50 TM; Baxter, Maurepas, achieve a cytogenetic response (partial or complete). 10 More France) according to the manufacturer's instructions. The recent comparative studies suggest that the survival of patients purity of the CD34 + population was assessed by flow cytometry after staining with the monoclonal HPCA-2-FITC (Becton Dickinson, Pont de Claix, France). The purity of the cells was The analysis was done on 100 cells in each cell culture conby trypan blue exclusion assay. Experiments were performed dition. Overlapping or damaged nuclei were excluded as in subdued light to avoid degradation of ATRA. In control were any with high levels of background fluorescence. The experiments DMSO alone was used to take into account the input cells (100% Ph positive) were used as positive control. differentiating properties of this molecule.
22
Cells from cytapheresis samples from lymphoma patients in remission were used as negative controls.
CFU-GM assays
Expression of results and statistics
CD34
+ cells (2 × 10 3 cells/ml) were plated in semi-solid methylcellulose medium (10% FCS, 30% IMDM, 0.4% human
Results from the semi-solid culture assays were expressed as serum albumin, 10% conditioned medium) from the bladder the number of clonogenic elements (colonies plus clusters) carcinoma cell line 5637 as a source of growth factors. Plates and reported as percentage to the control (mean ± s.e.). Conwere incubated at 37°C. All assays were performed in duplitrol with DMSO only was included any time when applicable. cate. CFU-GM and CFU-M were evaluated at days 7, 14 and Paired Student's t-test was used to calculate statistical signifi-21. Colonies (more than 40 cells) and clusters (10-40 cells) cance. P was considered significant when Ͻ0.05. were scored using an inverted microscope. Colony type was determined by their characteristic appearance and confirmed by May-Grü nwald-stained cytocentrifuged preparations of Results picked-up colonies. In some experiments a combination of IL-1 (500 U/ml; Hoffmann-LaRoche, Nutley, NJ, USA), Effects of IFN␣ on CML hematopoietic progenitors (10 ng/ml; Behring, Marburg, Germany) GM-CSF (10 ng/ml; Behring), M-CSF (10 ng/ml, Sandoz, Basel, Switzerland) was
To assess the effects of IFN␣ on CML hematopoietic progeniused in place of 5637 cell line-conditioned medium.
tors CD34 + cells were incubated for 24 h with increasing concentrations of IFN␣, ranging from 10 IU/ml to 10 6 IU/ml, and
Detection of BCR-ABL mRNA the cells plated for CFC assay in methylcellulose. Results show a dose-dependent inhibition of the generation of day 14 CFUSingle colonies were picked separately. Pools of 10 colonies GM ( Figure 1 ). More than 50% inhibition was observed for were used for mRNA extraction with guanidium isothiocyconcentrations of IFN␣ ranging at 1000 IU/ml. Therefore this anate (RNA TM solution; Bioprobe Systems, Montreuil sous concentration was chosen as working concentration for the bois, France). Four micrograms of MS2 phage RNA (Gibco next series of experiments. We next investigated whether IFN␣ BRL, Grand Island, NY, USA) were added as a carrier. Reverse could differentially inhibit day 7, day 14 or day 21 CFU-GM transcription was carried out using 5 units of rTth DNA polyin the same experimental protocol. Day 14 CFU-GM were merase (Perkin Elmer Cetus, Emeryville, CA, USA) at 70°C for moderately but significantly reduced (68 ± 9% of control 15 min, with a 3′ BCR primer (1 mM). The RT product was (P Ͻ 0.05)). Day 7 CFU-GM were deeply inhibited (37 ± 9% divided into two tubes, one for the amplification of BCR-ABL of control (P Ͻ 0.05)) indicating that late progenitors were with BCR-ABL 5′ and 3′ primers, dNTP, MgCl 2 chelating more sensitive to the action of IFN␣. Day 21 CFU-GM frebuffer and the other one for amplification of ABL as a control.
quency was not significantly modified ( Figure 2 ). PCR was carried out for 40 cycles of 1 min at 94°C and 1 min at 70°C. PCR samples were analyzed in an ethidium bromidestained 2% agarose gel. Effect of IFN␣ on CD34 + CML progenitors. Dose-effect and then plated on semi-solid medium. CFU-GM scoring was done experiments were performed to check for concentrations of IFN␣ givat day 14. Results are an average of two independent experiments. ing 50% inhibition of CFU-GM generation. Isolated CD34 + cells from chronic phase CML were incubated for 24 h in the presence of increasing concentrations of IFN␣ and then plated on semi-solid medium. CFU-GM scoring was performed at day 14. Results are an average of two independent experiments.
Figure 4
Effect of ATRA on CD34 + progenitors: day 7, day 14 and day 21 CFU-GM generation. Isolated CD34 + cells from chronic phase CML were incubated for 24 h in the presence of 10 −8 M ATRA and then plated on semi-solid medium. Scoring was done at day 7, day 14 and day 21. Results are expressed as percentage of control (number Figure 2 Effect of IFN␣ on CD34 + CML progenitors: day 7, day 14 of experiments n = 11). and day 21 CFU-GM generation. Isolated CD34 + cells from chronic phase CML were incubated for 24 h in the presence of 1000 IU/ml IFN␣ and then plated on semi-solid medium. Scoring was done at day when used at this concentration. CFU-M colonies were gener- of a combination of IL-1, IL-3, SCF, G-CSF, GM-CSF and M-CSF in place of 5637-conditioned medium did not improve the number of CFU-M. The generation of day 21 CFU-M was appeared to have no effect or to be moderately stimulatory on the generation of day 14 or day 21 CFU-GM whereas at higher moderately inhibited by 10 −8 M concentration of ATRA (Table 1) . Concentration of 10 −8 M was therefore chosen for concentrations there was a dose-dependent inhibition (Figures 3 and 4) . Late progenitors, however, were sensitive to further experiments, in order to analyze a possible synergistic effect with the inhibitory activity of IFN␣. We next investithis concentration of ATRA as day 7 CFU-GM were significantly inhibited (Figure 4) . These results seem to indicate that gated the effects of the combination of ATRA and IFN␣ on CML progenitors. CD34 + cells were incubated for 24 h with most CML immature progenitors are not affected by ATRA Table 2 Effects of ATRA and/or IFN␣ on day 14 CFU-GM gener- Table 1 Effects of ATRA and/or IFN␣ on CFU-M and CFU-GM generated at day 14 
Isolated CD34
+ cells from normal bone marrow (BM) or cord blood (CB) were incubated for 24 h in the presence of IFN␣ (1000 IU/ml) Results are expressed as the number (±s.e., n = 3) of CFU-M or CFU-GM for 2 × 10 3 plated cells. or ATRA (10 −8 M) or a combination of both and then plated on methylcellulose Table 3 Results from be significantly effective on day 7 and day 21 CFU-GM. Day 7 CFU-GM were reduced to 13 ± 4% (P Ͻ 0.05), and day 21
Comparison was made on day 14 CFU-GM determination for both CFU-GM to 38 ± 11% (P Ͻ 0.05) of control (data not shown). + cells was 42 ± 8, 71 ± 8, the expression of the BCR-ABL mRNA studied by RT-PCR. 41 ± 10, for day 7, day 14 and day 21, respectively. The
Internal positive control was the expression of the ABL mRNA. amplitude of s.e. was due to the variation in cloning efficiency Colonies negative for BCR-ABL mRNA were observed both from patient to patient. The synergy between ATRA and IFN␣ with IFN␣ alone or ATRA alone (four out of 14 (28%) and was also significant when the analysis was performed on the three out of 15 (20%), respectively). Colonies generated in the total colonies count instead of the percentage of control (IFN␣ presence of the combination of ATRA and IFN␣ appeared vs control P = 0.02, ATRA + IFN␣ vs IFN␣ P Ͻ 0.001). The consistently to have a higher negativity for BCR-ABL mRNA inhibitory effect of ATRA and IFN␣ significantly also persisted ((five out of nine) (55%)). Colonies generated by unmanipulwhen counts of colonies were pooled (day 7, 14, 21; data ated, ie incubated in the absence of ATRA and IFN␣ were all not shown).
positive for BCR-ABL mRNA (16/16, 100%). However, most of the colonies generated in the presence of the combination were clusters and microclusters and therefore too small to be analyzed by RT-PCR. For this reason we could not attain a Sensitivity of normal CD34 + cells to ATRA, IFN␣ or number of colonies sufficient for statistical analysis.
the combination of ATRA and IFN␣ CD34 + cells from normal bone marrow and cord blood were Higher number of Ph-negative cells, FISH analysis: All the samples studied were 100% Ph positive in the input of the analyzed for their sensitivity to either ATRA, IFN␣ or the combination of both. IFN␣ at a concentration of 1000 IU/ml or culture. Three samples from three different patients were analyzed. We only tested fresh CML cells at diagnosis in chronic ATRA at a concentration of 10 −8 M had no significant inhibitory effects (Tables 2 and 3 ). The combination of both drugs, phase. The percentage of Ph-negative cells detected after 7-day liquid culture was evaluated and we observed an however, was found significantly to inhibit day 14 CFU-GM from normal CD34 cells (30 ± 7% of control, average of five increased number of Ph-negative cells after treatment with the combination of ATRA plus IFN␣ (Table 4) . experiments).
alone to inhibit leukemic progenitors in CML. Firstly, retinoids like ATRA have been shown to be able to induce cellular differentiation in vitro and have been proposed as therapeutic agents in diseases characterized by a blocking of the differentiation of hematopoietic cells such as acute myeloid leukemia or myelodysplasic syndromes. A striking feature of acute promyelocytic leukemia blast cells is their sensitivity to retinoic acid-induced differentiation. 15, 16 In CML, there is usually a progressive blockage of differentiation during the course of the disease which coincides with resistance to treatment. It would therefore be of interest to try to interfere with this blockage. 25 Secondly, retinoids have been shown to inhibit late normal hematopoietic progenitors in human and early normal hematopoietic progenitors in mice. 26, 27 However, the direct effects of retinoids on normal human progenitors seem to be complex, being inhibitory on CFU-M and BFU-E growth and possibly stimulatory on CFU-G growth. 17, 28 There is little information regarding the effect of retinoids on CML hematopoietic progenitors. Our results indicate that 10 −8 M concentrations of ATRA had no inhibitory effect on early progenitors (day 14 and day 21 colonies) whereas late progenitors (day 7 colonies) are significantly inhibited. Concentration of ATRA in the range of 0.5-0.05 nM has been shown to be stimulatory on day 11 granulocytic colony formation from normal bone marrow progenitors; this stimulatory CFU-GM whereas concentrations only above 10 −6 M appear to be inhibitory on normal progenitors. 17 ATRA significantly synergizes with IFN␣ to inhibit the generation of day 14 CFU- Table 4 Higher number of Ph-negative cells after liquid culture in the presence of ATRA and IFN␣
GM from CML CD34
+ cells (Table 3 ). This synergy also significantly operates with normal CD34 + cells, however, com-
parison of inhibitory effects of the combination ATRA + IFN␣ vs IFN␣ on the generation of day 14 CFU-GM showed that
the significance of this inhibition is higher with CML CD34 + negative cells cells than with normal CD34 + cells (Table 3) . Our results also indicate that the combination of ATRA and IFN␣ is profoundly have been found to increase the antiproliferative activity of interferons in carcinoma and breast tumor cell lines 19 and it has been reported that IFN␣ might in vivo restore the sensiDiscussion tivity to ATRA in acute promyelocytic leukemia. 30 This combination acts synergistically to induce differentiation of the In this work we present evidence that ATRA potentializes the IFN␣ inhibitory effect on CML hematopoietic progenitors. We HL60 cell line and several acute nonlymphoblastic leukemias. 25 In this study, we show that ATRA acts synergistically used a short-term liquid culture protocol because such a liquid culture protocol may more closely reflect an in vitro with IFN␣ to inhibit CFU-GM generation in chronic phase CML. The use of CD34 + cells suggests that the observed purging of leukemic cells than culture protocols where IFN␣ and/or ATRA are directly added to the semi-solid methylcelluinhibitory effects of this combination might be direct. One report by Sagayadan et al 31 found no significant inhibitory lose medium. IFN␣ alone was found, as already reported 23 to preferentially inhibit late CML progenitors in a dose-depeneffect on day 10-12 CFU-GM starting with MNC from chronic phase CML. 31 However, Zheng et al 32 recently reported a sigdent manner. The absence of inhibition of normal progenitors at this concentration and in this short-term culture protocol nificant decrease in day 10-14 GM colony formation in CML in the presence of the association of ATRA and IFN␣. Also, may indicate an enhanced sensitivity of CML progenitors compared to normal one. 24 This differential effect may be due this combination appeared to have profound effects on CML cells in vivo as judged by the fall in the white blood cell count to the presence of a more important compartment of late progenitors in CML (actively cycling) than in normal blood. and the percentage of S-phase cells in a recent report. 33 Our study shows, moreover, that the association appears to be We tested ATRA in combination with IFN␣ to analyze whether this combination could be more effective than IFN␣ active on early as well as late progenitors. The percentage of
